$MD
Pediatrix Medical Group, Inc.

2016 Q3 Form 10-Q Financial Statement

#000119312516749764 Filed on October 27, 2016

View on sec.gov

Income Statement

Concept 2016 Q3 2015 Q4 2015 Q3
Revenue $828.0M $741.7M $722.3M
YoY Change 14.64% 14.02% 15.29%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $615.3M $546.5M $530.2M
YoY Change 16.05% 15.78% 16.43%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $24.19M $18.15M $16.92M
YoY Change 42.95% 30.54% 48.98%
% of Gross Profit
Operating Expenses $671.1M $590.8M $571.1M
YoY Change 17.5% 15.97% 16.95%
Operating Profit $156.9M $151.0M $151.1M
YoY Change 3.81% 7.0% 9.4%
Interest Expense $17.22M $8.493M $6.201M
YoY Change 177.62% 156.35% 207.13%
% of Operating Profit 10.97% 5.63% 4.1%
Other Income/Expense, Net -$16.20M -$6.965M -$4.850M
YoY Change 233.98% 214.73% 563.47%
Pretax Income $140.7M $144.0M $146.3M
YoY Change -3.82% 3.69% 6.45%
Income Tax $44.27M $51.58M $55.64M
% Of Pretax Income 31.47% 35.82% 38.04%
Net Earnings $96.51M $92.70M $90.78M
YoY Change 6.31% 4.87% 5.31%
Net Earnings / Revenue 11.66% 12.5% 12.57%
Basic Earnings Per Share $1.04 $1.00 $0.98
Diluted Earnings Per Share $1.04 $0.99 $0.97
COMMON SHARES
Basic Shares Outstanding 92.60M shares 92.79M shares 92.95M shares
Diluted Shares Outstanding 93.15M shares 93.54M shares 93.65M shares

Balance Sheet

Concept 2016 Q3 2015 Q4 2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $63.30M $60.40M $68.90M
YoY Change -8.13% 11.85% -12.9%
Cash & Equivalents $52.81M $51.57M $60.92M
Short-Term Investments $10.50M $8.900M $8.000M
Other Short-Term Assets $11.96M $12.97M $11.98M
YoY Change -0.2% 64.13% 10.76%
Inventory
Prepaid Expenses $13.25M $9.639M $10.04M
Receivables $487.0M $444.7M $406.8M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $575.5M $527.8M $573.2M
YoY Change 0.4% 13.0% 19.15%
LONG-TERM ASSETS
Property, Plant & Equipment $98.50M $83.63M $82.87M
YoY Change 18.85% 26.63% 30.31%
Goodwill $3.829B $3.366B $3.348B
YoY Change 14.37% 21.25% 25.89%
Intangibles $671.7M $424.2M
YoY Change 114.1%
Long-Term Investments $79.10M $63.30M $59.30M
YoY Change 33.39% -1.25% -4.05%
Other Assets $90.22M $82.15M $483.4M
YoY Change -81.34% 123.6% 127.53%
Total Long-Term Assets $4.768B $4.019B $3.973B
YoY Change 20.01% 27.96% 32.57%
TOTAL ASSETS
Total Short-Term Assets $575.5M $527.8M $573.2M
Total Long-Term Assets $4.768B $4.019B $3.973B
Total Assets $5.344B $4.547B $4.546B
YoY Change 17.54% 26.02% 30.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $23.35M $21.97M $22.34M
YoY Change 4.5% -32.99% 0.75%
Accrued Expenses $339.9M $373.8M $329.3M
YoY Change 3.22% 7.44% 18.41%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $19.60M $10.00M $11.80M
YoY Change 66.1% 0.0% 3833.33%
Total Short-Term Liabilities $413.0M $428.8M $404.6M
YoY Change 2.09% 3.0% 22.87%
LONG-TERM LIABILITIES
Long-Term Debt $1.769B $1.260B $1.351B
YoY Change 31.0% 126.1% 368.6%
Other Long-Term Liabilities $46.50M $52.29M $57.22M
YoY Change -18.74% -11.32% 4.98%
Total Long-Term Liabilities $46.50M $1.313B $57.22M
YoY Change -18.74% 112.96% 4.98%
TOTAL LIABILITIES
Total Short-Term Liabilities $413.0M $428.8M $404.6M
Total Long-Term Liabilities $46.50M $1.313B $57.22M
Total Liabilities $2.677B $2.109B $2.213B
YoY Change 20.96% 57.1% 127.39%
SHAREHOLDERS EQUITY
Retained Earnings $1.707B $1.510B $1.415B
YoY Change 20.7% 9.7% -11.83%
Common Stock $959.9M $927.2M $918.5M
YoY Change 4.51% 4.43% 91473.38%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.667B $2.438B $2.333B
YoY Change
Total Liabilities & Shareholders Equity $5.344B $4.547B $4.546B
YoY Change 17.54% 26.02% 30.71%

Cashflow Statement

Concept 2016 Q3 2015 Q4 2015 Q3
OPERATING ACTIVITIES
Net Income $96.51M $92.70M $90.78M
YoY Change 6.31% 4.87% 5.31%
Depreciation, Depletion And Amortization $24.19M $18.15M $16.92M
YoY Change 42.95% 30.54% 48.98%
Cash From Operating Activities $196.1M $104.1M $172.2M
YoY Change 13.88% -41.78% 8.03%
INVESTING ACTIVITIES
Capital Expenditures -$9.200M -$7.200M -$7.200M
YoY Change 27.78% 7.46% 100.0%
Acquisitions
YoY Change
Other Investing Activities -$534.1M -$17.40M -$237.1M
YoY Change 125.26% -87.04% 10.79%
Cash From Investing Activities -$543.4M -$24.60M -$244.3M
YoY Change 122.43% -82.55% 12.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 348.1M -88.90M 67.80M
YoY Change 413.42% 44.32% -39.63%
NET CHANGE
Cash From Operating Activities 196.1M 104.1M 172.2M
Cash From Investing Activities -543.4M -24.60M -244.3M
Cash From Financing Activities 348.1M -88.90M 67.80M
Net Change In Cash 800.0K -9.400M -4.300M
YoY Change -118.6% -60.5% -107.96%
FREE CASH FLOW
Cash From Operating Activities $196.1M $104.1M $172.2M
Capital Expenditures -$9.200M -$7.200M -$7.200M
Free Cash Flow $205.3M $111.3M $179.4M
YoY Change 14.44% -40.0% 10.06%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
3500000
CY2016Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2016Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
958953000
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
60915000
CY2016Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
363291000
CY2016Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
30121000
CY2016Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
93572000 shares
CY2016Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
93572000 shares
CY2016Q3 us-gaap Assets
Assets
5343864000
CY2016Q3 us-gaap Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount
BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
151100000
CY2016Q3 us-gaap Assets Current
AssetsCurrent
575457000
CY2016Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1172347000
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
52805000
CY2016Q3 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
15500000
CY2016Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
486957000
CY2016Q3 us-gaap Common Stock Value
CommonStockValue
936000
CY2016Q3 us-gaap Business Combination Liabilities Arising From Contingencies Amount Recognized
BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized
19900000
CY2016Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
23346000
CY2016Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
184450000
CY2016Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
267833000
CY2016Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1659304000
CY2016Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2016Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2016Q3 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
79146000
CY2016Q3 us-gaap Malpractice Loss Contingency Accrual Undiscounted Noncurrent
MalpracticeLossContingencyAccrualUndiscountedNoncurrent
179985000
CY2016Q3 us-gaap Other Assets Current
OtherAssetsCurrent
11958000
CY2016Q3 us-gaap Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount
70867000
CY2016Q3 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
864000000
CY2016Q3 us-gaap Malpractice Loss Contingency Accrual Undiscounted Current
MalpracticeLossContingencyAccrualUndiscountedCurrent
26988000
CY2016Q3 us-gaap Goodwill
Goodwill
3828807000
CY2016Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
671742000
CY2016Q3 us-gaap Liabilities
Liabilities
2676527000
CY2016Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5343864000
CY2016Q3 md Accrued Payroll Taxes And Benefits Current
AccruedPayrollTaxesAndBenefitsCurrent
64938000
CY2016Q3 md Long Term Debt And Capital Lease Obligations Excluding Long Term Line Of Credit
LongTermDebtAndCapitalLeaseObligationsExcludingLongTermLineOfCredit
905181000
CY2016Q3 md Accrued Contingent Consideration Liability Current
AccruedContingentConsiderationLiabilityCurrent
7086000
CY2016Q3 md Business Acquisition Number Of Entities Acquired
BusinessAcquisitionNumberOfEntitiesAcquired
14 Company
CY2016Q3 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
10489000
CY2016Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
46495000
CY2016Q3 us-gaap Liabilities Current
LiabilitiesCurrent
413033000
CY2016Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
13248000
CY2016Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
41599000
CY2016Q3 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
8100000
CY2016Q3 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
19621000
CY2016Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
90217000
CY2016Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q3 us-gaap Held To Maturity Securities Debt Maturities After Five Through Ten Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount
8279000
CY2016Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
98495000
CY2016Q3 us-gaap Stockholders Equity
StockholdersEquity
2667337000
CY2016Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2667337000
CY2016Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
11400000
CY2016Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1707448000
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
4500000 shares
CY2016Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q3 us-gaap Interest Payable Current
InterestPayableCurrent
14884000
CY2016Q3 md Accounts Payable And Accrued Liabilities Excluding Accrued Income Taxes Current
AccountsPayableAndAccruedLiabilitiesExcludingAccruedIncomeTaxesCurrent
363291000
CY2016Q3 md Unrecognized Tax Benefits Impact Effective Tax Rate
UnrecognizedTaxBenefitsImpactEffectiveTaxRate
10600000
CY2016Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
93637203 shares
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47928000
CY2015Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
395807000
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
21081000
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
93739000 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
93739000 shares
CY2015Q4 us-gaap Assets
Assets
4547214000
CY2015Q4 us-gaap Assets Current
AssetsCurrent
527769000
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
926235000
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1129301000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
51572000
CY2015Q4 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
14500000
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
444737000
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
937000
CY2015Q4 us-gaap Business Combination Liabilities Arising From Contingencies Amount Recognized
BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized
24900000
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
21969000
CY2015Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
233499000
CY2015Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
188956000
CY2015Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1574038000
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2015Q4 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
63288000
CY2015Q4 us-gaap Malpractice Loss Contingency Accrual Undiscounted Noncurrent
MalpracticeLossContingencyAccrualUndiscountedNoncurrent
176532000
CY2015Q4 us-gaap Other Assets Current
OtherAssetsCurrent
12968000
CY2015Q4 us-gaap Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount
60383000
CY2015Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
343500000
CY2015Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
424219000
CY2015Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
7000000
CY2015Q4 us-gaap Liabilities
Liabilities
2109368000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4547214000
CY2015Q4 us-gaap Malpractice Loss Contingency Accrual Undiscounted Current
MalpracticeLossContingencyAccrualUndiscountedCurrent
25995000
CY2015Q4 us-gaap Goodwill
Goodwill
3366150000
CY2015Q4 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
8853000
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
52289000
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
428771000
CY2015Q4 us-gaap Minority Interest
MinorityInterest
318000
CY2015Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
9639000
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
32145000
CY2015Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
13900000
CY2015Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
11883000
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
82154000
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2015Q4 us-gaap Held To Maturity Securities Debt Maturities After Five Through Ten Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount
2905000
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
83634000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
2437528000
CY2015Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2437846000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1510356000
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q4 us-gaap Interest Payable Current
InterestPayableCurrent
2655000
CY2015Q4 md Accounts Payable And Accrued Liabilities Excluding Accrued Income Taxes Current
AccountsPayableAndAccruedLiabilitiesExcludingAccruedIncomeTaxesCurrent
395807000
CY2015Q4 md Accrued Payroll Taxes And Benefits Current
AccruedPayrollTaxesAndBenefitsCurrent
58979000
CY2015Q4 md Long Term Debt And Capital Lease Obligations Excluding Long Term Line Of Credit
LongTermDebtAndCapitalLeaseObligationsExcludingLongTermLineOfCredit
919320000
CY2015Q4 md Accrued Contingent Consideration Liability Current
AccruedContingentConsiderationLiabilityCurrent
13565000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
11467000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1236000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
12987000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
220522000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.61
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
23208000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
17623000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
1846500000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
24000000
us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
2.76
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
2442735000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
46079000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.59
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
257331000
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
2062000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-16000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2870000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
15954000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-11174000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
20382000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1183000
us-gaap Pro Forma Weighted Average Shares Outstanding Diluted
ProFormaWeightedAverageSharesOutstandingDiluted
94123000 shares
us-gaap Operating Expenses
OperatingExpenses
1631348000
us-gaap Net Income Loss
NetIncomeLoss
243618000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-341000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
395734000
us-gaap Interest Expense
InterestExpense
14617000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-823386000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
1227000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
235051000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
806304000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4480000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
928000 shares
us-gaap Operating Income Loss
OperatingIncomeLoss
406908000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
571808000
us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
2038256000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-52734000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-5744000
us-gaap Investment Income Net
InvestmentIncomeNet
1093000
us-gaap Malpractice Loss Contingency Period Increase Decrease
MalpracticeLossContingencyPeriodIncreaseDecrease
2814000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2350000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
152457000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
264565000
us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
19908000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
16722000
us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
2.73
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
94123000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
93195000 shares
us-gaap Weighted Average Basic Shares Outstanding Pro Forma
WeightedAverageBasicSharesOutstandingProForma
93195000 shares
us-gaap Profit Loss
ProfitLoss
243277000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
1056500000
us-gaap Share Based Compensation
ShareBasedCompensation
23960000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
1063000
md Payment Of Contingent Consideration Liability Financing
PaymentOfContingentConsiderationLiabilityFinancing
9040000
md Payment Of Contingent Consideration Liability Operating
PaymentOfContingentConsiderationLiabilityOperating
1045000
md Practice Salaries And Benefits
PracticeSalariesAndBenefits
1292431000
md Practice Supplies And Other Operating Expenses
PracticeSuppliesAndOtherOperatingExpenses
72316000
dei Entity Registrant Name
EntityRegistrantName
MEDNAX, INC.
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
3424000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2000 shares
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000893949
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
4077000
dei Document Period End Date
DocumentPeriodEndDate
2016-09-30
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1233000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
25900000
us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
2.73
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
2492022000
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
275523000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.67
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
64010000
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.65
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
15000000
us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
722200000
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
251873000
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
2625000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.388 pure
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1121000
us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
3300000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
592000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
16276000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
8930000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-43108000
us-gaap Payments For Previous Acquisition
PaymentsForPreviousAcquisition
9000000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
50868000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-8143000
us-gaap Pro Forma Weighted Average Shares Outstanding Diluted
ProFormaWeightedAverageSharesOutstandingDiluted
93045000 shares
us-gaap Operating Expenses
OperatingExpenses
1923480000
us-gaap Net Income Loss
NetIncomeLoss
246835000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-318000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
385801000
us-gaap Interest Expense
InterestExpense
46736000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-771909000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
32240000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
24812000
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
718700000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
1661000000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
61828000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
724861000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
92336000 shares
dei Trading Symbol
TradingSymbol
MD
us-gaap Weighted Average Basic Shares Outstanding Pro Forma
WeightedAverageBasicSharesOutstandingProForma
92336000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
709000 shares
us-gaap Operating Income Loss
OperatingIncomeLoss
428909000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
460312000
us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
2352389000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-32628000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-10279000
us-gaap Investment Income Net
InvestmentIncomeNet
1249000
us-gaap Malpractice Loss Contingency Period Increase Decrease
MalpracticeLossContingencyPeriodIncreaseDecrease
3453000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2379000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
139284000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
312830000
us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
28420000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
15599000
us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
2.71
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
93045000 shares
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
900000 shares
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
61800000
us-gaap Profit Loss
ProfitLoss
246517000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
1148000000
us-gaap Share Based Compensation
ShareBasedCompensation
25889000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
1601000
md Payment Of Contingent Consideration Liability Financing
PaymentOfContingentConsiderationLiabilityFinancing
8282000
md Payment Of Contingent Consideration Liability Operating
PaymentOfContingentConsiderationLiabilityOperating
735000
md Number Of Anesthesiology Practices Acquired
NumberOfAnesthesiologyPracticesAcquired
7 Company
md Number Of Physician Group Practices Acquired
NumberOfPhysicianGroupPracticesAcquired
12 Company
md Practice Salaries And Benefits
PracticeSalariesAndBenefits
1498268000
md Increase Decrease In Accrued Payroll Taxes And Benefits
IncreaseDecreaseInAccruedPayrollTaxesAndBenefits
49000000
md Number Of Neonatology Practices Acquired
NumberOfNeonatologyPracticesAcquired
1 Company
md Practice Supplies And Other Operating Expenses
PracticeSuppliesAndOtherOperatingExpenses
85679000
md Number Of Patient Engagement Software Company Acquired
NumberOfPatientEngagementSoftwareCompanyAcquired
1 Company
md Number Of Pediatric Subspecialty Practices Acquired
NumberOfPediatricSubspecialtyPracticesAcquired
2 Company
md Number Of Maternalfetal Medicine Practices Acquired
NumberOfMaternalfetalMedicinePracticesAcquired
1 Company
md Number Of Pediatric Cardiology Practices Acquired
NumberOfPediatricCardiologyPracticesAcquired
1 Company
md Number Of Thirdparty Receivables Companies Acquired
NumberOfThirdpartyReceivablesCompaniesAcquired
1 Company
CY2015Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8200000
CY2015Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
80185000
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.98
CY2015Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16918000
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.97
CY2015Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4850000
CY2015Q3 us-gaap Operating Expenses
OperatingExpenses
571143000
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
90781000
CY2015Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-141000
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
146280000
CY2015Q3 us-gaap Interest Expense
InterestExpense
6201000
CY2015Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
697000 shares
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
151130000
CY2015Q3 us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
722273000
CY2015Q3 us-gaap Investment Income Net
InvestmentIncomeNet
567000
CY2015Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
784000
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
55640000
CY2015Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
93646000 shares
CY2015Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
92949000 shares
CY2015Q3 us-gaap Profit Loss
ProfitLoss
90640000
CY2015Q3 md Practice Salaries And Benefits
PracticeSalariesAndBenefits
450033000
CY2015Q3 md Practice Supplies And Other Operating Expenses
PracticeSuppliesAndOtherOperatingExpenses
24007000
CY2016Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8700000
CY2016Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
93457000
CY2016Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.04
CY2016Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
24185000
CY2016Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.04
CY2016Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-16198000
CY2016Q3 us-gaap Operating Expenses
OperatingExpenses
671115000
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
96509000
CY2016Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-88000
CY2016Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
140693000
CY2016Q3 us-gaap Interest Expense
InterestExpense
17215000
CY2016Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
542000 shares
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
156891000
CY2016Q3 us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
828006000
CY2016Q3 us-gaap Investment Income Net
InvestmentIncomeNet
221000
CY2016Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
796000
CY2016Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
44272000
CY2016Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
93146000 shares
CY2016Q3 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
17600000
CY2016Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
92604000 shares
CY2016Q3 us-gaap Profit Loss
ProfitLoss
96421000
CY2016Q3 md Practice Salaries And Benefits
PracticeSalariesAndBenefits
521832000
CY2016Q3 md Practice Supplies And Other Operating Expenses
PracticeSuppliesAndOtherOperatingExpenses
31641000

Files In Submission

Name View Source Status
0001193125-16-749764-index-headers.html Edgar Link pending
0001193125-16-749764-index.html Edgar Link pending
0001193125-16-749764.txt Edgar Link pending
0001193125-16-749764-xbrl.zip Edgar Link pending
d269319d10q.htm Edgar Link pending
d269319dex311.htm Edgar Link pending
d269319dex312.htm Edgar Link pending
d269319dex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
md-20160930.xml Edgar Link completed
md-20160930.xsd Edgar Link pending
md-20160930_cal.xml Edgar Link unprocessable
md-20160930_def.xml Edgar Link unprocessable
md-20160930_lab.xml Edgar Link unprocessable
md-20160930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending